Modern Chinese Medicine Group Co., Ltd. (1643.HK)
HKD 0.36
(-5.33%)
HKD 0.36
(-5.33%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -286.19 Million CNY | -1.54% |
| 2022 | -281.86 Million CNY | -60.44% |
| 2021 | -175.68 Million CNY | -159.68% |
| 2020 | -67.65 Million CNY | -119.01% |
| 2019 | -30.89 Million CNY | 65.65% |
| 2018 | -89.94 Million CNY | -599.11% |
| 2017 | -12.86 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -246.59 Million CNY | 0.0% |
| 2024 Q1 | -246.59 Million CNY | 13.84% |
| 2023 Q1 | -281.54 Million CNY | 0.11% |
| 2023 FY | -286.19 Million CNY | -1.54% |
| 2023 Q4 | -286.19 Million CNY | 0.03% |
| 2023 Q3 | -286.26 Million CNY | -1.73% |
| 2023 Q2 | -281.4 Million CNY | 0.05% |
| 2022 Q1 | -221.73 Million CNY | -26.21% |
| 2022 Q4 | -281.86 Million CNY | 0.14% |
| 2022 FY | -281.86 Million CNY | -60.44% |
| 2022 Q2 | -221.63 Million CNY | 0.04% |
| 2022 Q3 | -282.25 Million CNY | -27.35% |
| 2021 Q4 | -175.68 Million CNY | 0.19% |
| 2021 Q3 | -176.02 Million CNY | -1.42% |
| 2021 Q2 | -173.56 Million CNY | 0.2% |
| 2021 FY | -175.68 Million CNY | -159.68% |
| 2021 Q1 | -173.9 Million CNY | -157.05% |
| 2020 Q4 | -67.65 Million CNY | -19.83% |
| 2020 FY | -67.65 Million CNY | -119.01% |
| 2020 Q3 | -56.45 Million CNY | 0.0% |
| 2020 Q1 | 35.89 Million CNY | 216.19% |
| 2019 Q4 | -30.89 Million CNY | 0.0% |
| 2019 FY | -30.89 Million CNY | 65.65% |
| 2018 FY | -89.94 Million CNY | -599.11% |
| 2017 FY | -12.86 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | -12.45 Billion HKD | 97.701% |